Harvey Capital Management Inc Argenx Se Transaction History
Harvey Capital Management Inc
- $398 Million
- Q3 2024
A detailed history of Harvey Capital Management Inc transactions in Argenx Se stock. As of the latest transaction made, Harvey Capital Management Inc holds 14,094 shares of ARGX stock, worth $8.86 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
14,094
Previous 14,119
0.18%
Holding current value
$8.86 Million
Previous $6.07 Million
25.89%
% of portfolio
1.92%
Previous 1.6%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.66 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.21 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.56 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.07 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$778 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...